Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantation

International Urology and Nephrology

Volumn 40, Issue 2, 2008, Pages 515-520

  Sheashaa, Hussein A ^a   Hamdy, Ahmed F ^a   Bakr, Mohamed A ^a   Abdelbaset, Sherif F ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Bolus ATG; Induction therapy; Live donor kidney transplantation

Indexed keywords

GLUCOCORTICOID; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PLASMAPHERESIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTILYMPHOCYTE SERUM; FEMALE; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; METHYLPREDNISOLONE; PLASMA EXCHANGE; PROSPECTIVE STUDIES;

EID: 52649115248     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-007-9242-6     Document Type: Article

References (14)

1. Sollinger H, Kaplan B, Pescovitz M et al (2001) Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection. Transplantation 72:1915-1919
2. Brennan DC, Flavin K, Lowell JA et al (1999) A randomized, double-blinded comparison of thymogloublin versus ATGAM for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 67:1011-1018
3. Bock HA, Gallati H, Zürcher RM et al (1995) A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 59:830-840
4. Kaden J, May G, Muller P et al (1995) Intraoperative anti- T-lymphocyte globulin bolus in addition to triple drug therapy improves kidney graft survival. Transplant Proc 27:1060-1061
5. Agha IA, Rueda J, Alvarez A et al (2002) Short course induction immunosuppression with thymoglobulin for renal transplant recipients. Transplantation 73:473-475
6. Goggins WC, Pascual MA, Powelson JA et al (2003) A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 76:798-802
7. Yussin A, Shapira Z (2000) Single-bolus high - dose ATG for prophylaxis of rejection in renal transplantation- a prospective, randomized study. Transpl Int 13:S293-S294
8. Henry ML (1997) Induction therapy. Curr Opin Organ transplant 2:49-53
9. Danovitch GM (2005) Immunosuppressive medications and protocols for kidney transplantation. In: Danovitch GM (ed) Handbook of kidney transplantation, 4th edn. Lippincott and Wilkins, Boston, pp 72-133
10. Racusen L, Solez K, Colvin R et al (1999) The Banff 97 working classification of renal allograft pathology. Kidney Int 55:713-723
11. Shapiro R, Jordan ML, Basu A et al (2003) Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 238:520-525
12. Samsel R, Chmura A, Wlodarczyk Z et al (1999) Perioperative single high dose ATG-Fresenius S administration as induction immunosuppressive therapy in cadaveric renal transplantation preliminary results. Ann Transplant 4(2):37-39
13. Khauli RB, Houjaij A, Sawah S et al (2005) Observations on quadruple immunosuppression maintenance therapy using rapamycin, low-dose cyclosporine, mycophenolate mofetil, and prednisone following ATG induction. Transplant Proc 37(7):3031-3033
14. Abou-Jaoude MM, Almawi WY (2003) Intraoperative antithymocyte globulin-Fresenius (ATG-F) administration as induction immunosuppressive therapy in kidney transplantation. Mol Immunol 39(17-18):1089-1094